MCL1 and plasma cell myeloma: For instance, high MCL1 expression in multiple myeloma was correlated with recurrence after chemotherapy and shorter survival [22] and mice bearing MCL1 overexpressing lymphomas were less sensitive to cyclophosphamide treatment in vivo [23].